Procurement Summary
Country : Poland
Summary : Purchase of Antiretroviral Drugs. Parts 1-3
Deadline : 19 May 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117886393
Document Ref. No. : 255047-2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : PLN 13344000
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
1 25mg tablet 30
Part 2: Darunavir/Cobicistat | 800mg/150mg | 30
Part 3: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide | 800/150/200/10mg | tablet| 30
As described by the subject of the contract specified in the specification of the terms of the contract (SWZ) and on the conditions set out in the planned provisions of the contract (PPU), which constitute an attachment to SWZ.
1. International, chemical name of the medicinal product: rilpivirine
power or volume: 25mg
characterFarm.: Tablet
Package size: 30
Packaging number: 350
2. In question:
2.1. Pursuant to art. 105 and 106 of the Public Procurement Law in order to confirm the compliance of the offered supplies with the requirements, features or criteria specified in the description of the subject of the contract or the criteria for evaluation of offers orThe Employer requires the requirements related to the execution of the order from the contractors to provide the following documents:
2.1.1. An important, current permission for marketing permit on the RP, issued by the President of the Office for Registration of Medicinal Products, medical devices.and biocidal products or valid as at the date of submission of offers, current permit for marketing issued by the European Union Council or the European Commission.
2.2. The Employer allows the possibility of offering the subject of the contract in foreign -language packaging. The contractor must...
Document Type: Contract Notice
Reference Number: ZZP.ZP.411.62.2025
Contract Type: supplies
Estimated Value: 13344000 - PLN
Authority Type: cga
Doc Title: Zakup lekow antyretrowirusowych. Części 1-3
Dispatch Date: 2025-04-17
Publish Date: 2025-04-18
Submission Date: 2025-05-19
Documents
Tender Notice